• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Banca Mediolanum (BIT:BMED) Earnings Put Its Valuation Back In Focus

    Simply Wall St·08/03/2026 03:29:29
    Listen to the news

    Q2 2026 earnings put Banca Mediolanum in focus

    Banca Mediolanum (BIT:BMED) is in the spotlight after reporting second quarter 2026 net income of €279.4 million and first half net income of €555.5 million, both higher than the prior year figures.

    See our latest analysis for Banca Mediolanum.

    The Q2 2026 results arrive after a strong run in Banca Mediolanum's stock, with a 24.37% 90 day share price return and a 63.60% 1 year total shareholder return at a share price of €23.17, which extends multi year gains.

    If these earnings have you thinking about where else the market is rewarding consistent performance, it could be a good time to broaden your search with 106 top founder-led companies

    After Banca Mediolanum's strong price run and higher first half net income, some investors may see momentum while others worry about overpaying. So does it make more sense to commit now, or to wait for a pullback as valuation comes into focus?

    Most Popular Narrative: 2.2% Undervalued

    The most followed narrative for Banca Mediolanum places fair value at €23.68, slightly above the recent €23.17 close, which frames the latest earnings in a tight valuation range.

    The analysts have a consensus price target of €23.68 for Banca Mediolanum based on their expectations of its future earnings growth, profit margins and other risk factors. In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €2.7 billion, earnings will come to €1.2 billion, and it would be trading on a PE ratio of 18.4x, assuming you use a discount rate of 9.0%.

    Read the complete narrative.

    Want to understand why this fair value sits only slightly above today’s price? The narrative leans on modest revenue growth, lower margins, and a richer future earnings multiple. Curious which assumptions really carry the model and how sensitive that €23.68 figure is to even small changes?

    Result: Fair Value of €23.68 (UNDERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, if Banca Mediolanum keeps attracting strong inflows and new customers, or maintains its low cost base, the current undervalued narrative could be challenged.

    Find out about the key risks to this Banca Mediolanum narrative.

    Another view on Banca Mediolanum's valuation

    While the analyst narrative frames Banca Mediolanum as about 2.2% undervalued on fair value of €23.68 versus a €23.17 share price, the earnings multiple sends a different signal. The stock trades on a P/E of 13x, slightly above a fair ratio of 12.5x. This may indicate a smaller margin of safety than the model implies.

    See what the numbers say about this price — find out in our valuation breakdown.

    BIT:BMED P/E Ratio as at Aug 2026
    BIT:BMED P/E Ratio as at Aug 2026

    Next Steps

    With the mixed signals on Banca Mediolanum, do you see more to like or to worry about right now? Take a closer look at both sides of the story by reviewing the 2 key rewards and 2 important warning signs.

    Looking for more investment ideas beyond Banca Mediolanum?

    If Banca Mediolanum has sharpened your focus on quality, do not stop here. Casting a wider net can help you spot opportunities before the crowd.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.